SI-Bone Inc. is a medical technology company that specializes in the development and commercialization of innovative solutions for the treatment of musculoskeletal disorders related to the sacroiliac (SI) joint. Founded in 2008 and headquartered in Santa Clara, California, SI-Bone has become a leading player in the field, addressing the challenges associated with SI joint dysfunction and providing minimally invasive surgical solutions.
The company's flagship product is the iFuse Implant System, a unique triangular-shaped titanium implant designed for stabilization and fusion of the SI joint. The iFuse System is intended to address conditions such as sacroiliac joint dysfunction, a common cause of lower back pain. The minimally invasive nature of the procedure, involving the implantation of triangular-shaped implants, distinguishes it from traditional open surgery, offering patients a potentially quicker recovery and less postoperative discomfort.
SI-Bone has received regulatory approvals for the iFuse Implant System in various regions, including the United States and Europe. The company has actively pursued clinical studies and research to demonstrate the safety and efficacy of its products. The success of the iFuse System has contributed to SI-Bone's recognition as a key player in the orthopedic and spine surgery market.
In addition to its focus on product development, SI-Bone has engaged in strategic collaborations and partnerships to enhance its market presence and expand its offerings. The company's management team includes individuals with significant experience in the medical device industry, contributing to its growth and success.